Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2013-6660

2. Registrant Information.

Registrant Reference Number: 5089841

Registrant Name (Full Legal Name no abbreviations): Sure-Gro Inc.

Address: 150 Savannah Oaks Dr.

City: Brantford

Prov / State: Ontario

Country: Canada

Postal Code: N3V 1E7

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.


5. Location of incident.

Country: CANADA

Prov / State: ONTARIO

6. Date incident was first observed.


Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No. 24947      PMRA Submission No.       EPA Registration No.

Product Name: Total Wipeout Fast Control Weed and Grass Killer

  • Active Ingredient(s)

7. b) Type of formulation.

Application Information

8. Product was applied?


9. Application Rate.


10. Site pesticide was applied to (select all that apply).

Site: Res. - Out Home / Rés - à l'

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).


To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform III: Domestic Animal Incident Report

1. Source of Report

Animal's Owner

2. Type of animal affected

Dog / Chien

3. Breed

Miniature Poodle

4. Number of animals affected


5. Sex


6. Age (provide a range if necessary )


7. Weight (provide a range if necessary )



8. Route(s) of exposure


9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms


  • Gastrointestinal System
    • Symptom - Diarrhea
  • Nervous and Muscular Systems
    • Symptom - Ataxia
  • General
    • Symptom - Lethargy
    • Symptom - Hyperthermia

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.


14. a) Was the animal hospitalized?


14. b) How long was the animal hospitalized?

15. Outcome of the incident


16. How was the animal exposed?

Accidental ingestion/Ingestion accident.

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

The owner applied this product to her yard on Friday and Saturday. Shortly after the owner applied the product on Sat she noticed the pet in the area eating and licking some plants. The pet then became symptomatic Sat afternoon/evening, he began having diarrhea and displaying some lethargy. The pet has continued to have diarrhea since then, stayed lethargic and began experiencing some hindend weakness Sun morning. The owner was informed that Glufosinate is a phosphinic analog of glutamic acid, which is an excitatory amino acid in the CNS. The most common side effects from exposures to products containing glufosinate are vomiting and diarrhea. Large exposures could potentially lead to seizures, respiratory distress, and GI ulcerations. Discussed the case with DVM, Duffy is lethargic and weak in the HL's with ataxia. He also has R HL lameness and occasionally will hold that leg out. Respirations are normal, T is a little elevated, and ALK is elevated. Often with this product, GI signs can occur within the first few hours. With really large exposures there could be signs of tremors, seizures, and respiratory distress. would be more suspicious about other causes for his signs. Continue treating supportively

To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification


19. Provide supplemental information here

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.